Christopher R Mueller

Title: Christopher R Mueller: Innovator in Tumor Detection Technology

Introduction

Christopher R Mueller is a notable inventor based in Kingston, CA. He has made significant contributions to the field of cancer detection through his innovative methods. His work focuses on the detection of methylated tumor DNA, which has the potential to improve cancer diagnosis and monitoring.

Latest Patents

Christopher R Mueller holds 1 patent for his invention titled "Cell-free detection of methylated tumour DNA." This method allows for the detection of tumors using cell-free samples, such as circulating tumor DNA. The technique utilizes adjacent methylation signals within a single sequencing read to provide a positive tumor signal, thereby reducing false positives. The process involves extracting DNA from a cell-free sample, bisulfite converting the DNA, and amplifying regions that are methylated in cancer. This innovative approach enhances sensitivity and can be tailored to specific testing aims.

Career Highlights

Throughout his career, Christopher R Mueller has worked with prestigious institutions, including Institut Curie and the National Institute of Health and Medical Research. His experience in these organizations has contributed to his expertise in cancer research and detection technologies.

Collaborations

One of his notable collaborators is Marc-Henri Stern. Their partnership has likely fostered advancements in the field of tumor detection and cancer research.

Conclusion

Christopher R Mueller's innovative work in the detection of methylated tumor DNA represents a significant advancement in cancer diagnostics. His contributions have the potential to improve patient outcomes through more accurate and sensitive detection methods.